Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr:110:103-107.
doi: 10.1016/j.jhin.2021.01.006. Epub 2021 Jan 20.

Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study

Affiliations

Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study

E J Williams et al. J Hosp Infect. 2021 Apr.

Abstract

It can be a diagnostic challenge to identify patients with coronavirus disease 2019 in whom antibiotics can be safely withheld. This study evaluated the effectiveness of a guideline implemented at Sheffield Teaching Hospitals NHS Foundation Trust that recommends withholding antibiotics in patients with low serum procalcitonin (PCT), defined as ≤0.25 ng/mL. Results showed reduced antibiotic consumption in patients with PCT ≤0.25 ng/mL with no increase in mortality, alongside a reduction in subsequent carbapenem prescriptions during admission. The results support the effectiveness of this guideline, and further research is recommended to identify the optimal cut-off value for PCT in this setting.

Keywords: Antimicrobial stewardship; Bacterial co-infection; COVID-19; Procalcitonin; SARS-CoV-2; Superadded infection.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Antibiotic consumption as demonstrated by average defined daily dose (DDD, yellow bars) and average meropenem DDD (blue bars) between positive (>0.25 ng/mL) and negative (≤0.25 ng/mL) procalcitonin (PCT) groups, stratified by age.

Comment in

References

    1. Henry B.M., De Oliveira M.H.S., Benoit S., Plebani M., Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58 doi: 10.1515/cclm-2020-0369. - DOI - PubMed
    1. Lansbury L., Lim B., Baskaran V., Lim W.S. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81:266–275. - PMC - PubMed
    1. National Institute for Health and Care Excellence . NICE; London: 2020. COVID-19 rapid guideline: antibiotics for pneumonia in adults in hospital. NICE Guideline 173. - PubMed
    1. Docherty A.B., Harrison E.M., Green C.A., Hardwick H.E., Pius R., Norman L. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985. - PMC - PubMed
    1. Seaton R.A., Gibbons C.L., Cooper L., Malcolm W., McKinney R., Dundas S. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals. J Infect. 2020;81:952–960. - PMC - PubMed

MeSH terms